User menu

Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma.

Bibliographic reference Reddy, Srinevas K ; Hyder, Omar ; Marsh, J Wallis ; Sotiropoulos, Georgios C ; Paul, Andreas ; et. al. Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma.. In: Journal of gastrointestinal surgery, Vol. 17, no.4, p. 748-55 (2013)
Permanent URL http://hdl.handle.net/2078.1/128857
  1. Hashimoto Etsuko, Tokushige Katsutoshi, Prevalence, gender, ethnic variations, and prognosis of NASH, 10.1007/s00535-010-0311-8
  2. Pascale A, Pais R, Ratziu V. An overview of nonalcoholic steatohepatitis: past, present, and future directions. J Gastrointest Liver Dis 2010;19:415–23.
  3. Younossi Zobair M., Stepanova Maria, Afendy Mariam, Fang Yun, Younossi Youssef, Mir Hesham, Srishord Manirath, Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008, 10.1016/j.cgh.2011.03.020
  4. Michitaka Kojiro, , Nishiguchi Shuhei, Aoyagi Yutaka, Hiasa Yoichi, Tokumoto Yoshio, Onji Morikazu, Etiology of liver cirrhosis in Japan: a nationwide survey, 10.1007/s00535-009-0128-5
  5. Bhala Neeraj, Angulo Paul, van der Poorten David, Lee Eric, Hui Jason M., Saracco Giorgio, Adams Leon A., Charatcharoenwitthaya Phunchai, Topping Joanne H., Bugianesi Elisabetta, Day Christopher P., George Jacob, The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study, 10.1002/hep.24491
  6. Starley Brad Q., Calcagno Christopher J., Harrison Stephen A., Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection, 10.1002/hep.23594
  7. Page John M., Harrison Stephen A., NASH and HCC, 10.1016/j.cld.2009.07.007
  8. Cohen J. C., Horton J. D., Hobbs H. H., Human Fatty Liver Disease: Old Questions and New Insights, 10.1126/science.1204265
  9. Aly Fatima Zahra, Kleiner David E., Update on Fatty Liver Disease and Steatohepatitis : , 10.1097/pap.0b013e318220f59b
  10. Argo Curtis K., Northup Patrick G., Al-Osaimi Abdullah M.S., Caldwell Stephen H., Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis, 10.1016/j.jhep.2009.03.019
  11. Reddy Srinevas K., Steel Jennifer L., Chen Hui-Wei, DeMateo David J., Cardinal Jon, Behari Jaideep, Humar Abhinav, Marsh J. Wallis, Geller David A., Tsung Allan, Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease, 10.1002/hep.25536
  12. SEER Cancer Statistics Review, 1975–2000. SEER incidence and US mortality rates and trends for the top 15 cancer sites by race/ethnicity. http://seer.cancer.gov/csr/1975_2009_pops09/results_merged/topic_topfifteen.pdf
  13. SEER Cancer Statistics Review, 1975–2000. CSR sections—liver and bile duct. http://seer.cancer.gov/csr/1975_2009_pops2009/results_merged/sect_14_liver_bile.pdf
  14. Hashimoto Etsuko, Yatsuji Satoru, Tobari Maki, Taniai Makiko, Torii Nobuyuki, Tokushige Katsutoshi, Shiratori Keiko, Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis, 10.1007/s00535-008-2262-x
  15. Stickel F., Hellerbrand C., Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications, 10.1136/gut.2009.199661
  16. Ascha M, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010;51:1972–8.
  17. Tokushige Katsutoshi, Hashimoto Etsuko, Yatsuji Satoru, Tobari Maki, Taniai Makiko, Torii Nobuyuki, Shiratori Keiko, Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C, 10.1007/s00535-010-0237-1
  18. Kawada Natsuko, Imanaka Kazuho, Kawaguchi Tsukasa, Tamai Chie, Ishihara Ryu, Matsunaga Takashi, Gotoh Kunihito, Yamada Terumasa, Tomita Yasuhiko, Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis, 10.1007/s00535-009-0112-0
  19. Ratziu Vlad, Bonyhay Luminita, Di Martino Vincent, Charlotte Frederic, Cavallaro Lucas, Sayegh-Tainturier Marie-Hélène, Giral Philippe, Grimaldi André, Opolon Pierre, Poynard Thierry, Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis, 10.1053/jhep.2002.33324
  20. Bugianesi Elisabetta, Leone Nicola, Vanni Ester, Marchesini Giulio, Brunello Franco, Carucci Patrizia, Musso Alessandro, De Paolis Paolo, Capussotti Lorenzo, Salizzoni Mauro, Rizzetto Mario, Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma, 10.1053/gast.2002.34168
  21. Yasui Kohichiroh, Hashimoto Etsuko, Komorizono Yasuji, Koike Kazuhiko, Arii Shigeki, Imai Yasuharu, Shima Toshihide, Kanbara Yoshihiro, Saibara Toshiji, Mori Takahiro, Kawata Sumio, Uto Hirofumi, Takami Shiro, Sumida Yoshio, Takamura Toshinari, Kawanaka Miwa, Okanoue Takeshi, Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma, 10.1016/j.cgh.2011.01.023
  22. Yoshioka Yoko, Hashimoto Etsuko, Yatsuji Satoru, Kaneda Hiroyuki, Taniai Makiko, Tokushige Katsutoshi, Shiratori Keiko, Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH, 10.1007/s00535-004-1475-x
  23. Welzel Tania M., Mellemkjaer Lene, Gloria Gridley, Sakoda Lori C., Hsing Ann W., Ghormli Laure El, Olsen Jorgen H., McGlynn Katherine A., Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: A nationwide case-control study, 10.1002/ijc.22283
  24. de Jong Mechteld C., Nathan Hari, Sotiropoulos Georgios C., Paul Andreas, Alexandrescu Sorin, Marques Hugo, Pulitano Carlo, Barroso Eduardo, Clary Bryan M., Aldrighetti Luca, Ferrone Cristina R., Zhu Andrew X., Bauer Todd W., Walters Dustin M., Gamblin T. Clark, Nguyen Kevin T., Turley Ryan, Popescu Irinel, Hubert Catherine, Meyer Stephanie, Schulick Richard D., Choti Michael A., Gigot Jean-Francois, Mentha Gilles, Pawlik Timothy M., Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment, 10.1200/jco.2011.35.6519
  25. Eckel Robert H, Alberti KGMM, Grundy Scott M, Zimmet Paul Z, The metabolic syndrome, 10.1016/s0140-6736(09)61794-3
  26. Alberti K.G.M.M., Eckel R. H., Grundy S. M., Zimmet P. Z., Cleeman J. I., Donato K. A., Fruchart J.-C., James W. P. T., Loria C. M., Smith S. C., Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity, 10.1161/circulationaha.109.192644
  27. Ascha Mustafa S., Hanouneh Ibrahim A., Lopez Rocio, Tamimi Tarek Abu-Rajab, Feldstein Ariel F., Zein Nizar N., The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis, 10.1002/hep.23527
  28. Sanyal Arun J., Brunt Elizabeth M., Kleiner David E., Kowdley Kris V., Chalasani Naga, Lavine Joel E., Ratziu Vlad, McCullough Arthur, Endpoints and clinical trial design for nonalcoholic steatohepatitis, 10.1002/hep.24376
  29. Strasberg Steven M., Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system, 10.1007/s00534-005-0999-7
  30. , AJCC Cancer Staging Manual, ISBN:9783540005957, 10.1007/978-1-4757-3656-4
  31. Kleiner David E., Brunt Elizabeth M., Van Natta Mark, Behling Cynthia, Contos Melissa J., Cummings Oscar W., Ferrell Linda D., Liu Yao-Chang, Torbenson Michael S., Unalp-Arida Aynur, Yeh Matthew, McCullough Arthur J., Sanyal Arun J., , Design and validation of a histological scoring system for nonalcoholic fatty liver disease, 10.1002/hep.20701
  32. Brunt Elizabeth M., Kleiner David E., Wilson Laura A., Belt Patricia, Neuschwander-Tetri Brent A., , Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings, 10.1002/hep.24127
  33. Brunt Elizabeth M., Kleiner David E., Wilson Laura A., Unalp Aynur, Behling Cynthia E., Lavine Joel E., Neuschwander-Tetri Brent A., , Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network, 10.1002/hep.22724
  34. Chalasani Naga, Younossi Zobair, Lavine Joel E., Diehl Anna Mae, Brunt Elizabeth M., Cusi Kenneth, Charlton Michael, Sanyal Arun J., The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, 10.1002/hep.25762
  35. Kleiner David, Brunt Elizabeth, Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research, 10.1055/s-0032-1306421
  36. Kaplan E. L., Meier Paul, Nonparametric Estimation from Incomplete Observations, 10.1080/01621459.1958.10501452
  37. Welzel Tania M., Graubard Barry I., El–Serag Hashem B., Shaib Yasser H., Hsing Ann W., Davila Jessica A., McGlynn Katherine A., Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma in the United States: A Population-Based Case-Control Study, 10.1016/j.cgh.2007.05.020
  38. Lefkowitch Jay, Morawski John, Late Nonalcoholic Fatty Liver Disease with Cirrhosis: A Pathologic Case of Lost or Mistaken Identity, 10.1055/s-0032-1306429
  39. Welzel Tania M., Graubard Barry I., Zeuzem Stefan, El-Serag Hashem B., Davila Jessica A., McGlynn Katherine A., Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-medicare database, 10.1002/hep.24397
  40. Reddy SK, Marsh JW, Varley PR, Mock BK, Chopra KB, et al (2012) Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case–control study. Hepatology. doi: 10/1002/hep.25935
  41. Paradis Valérie, Zalinski Stéphane, Chelbi Emna, Guedj Nathalie, Degos Françoise, Vilgrain Valérie, Bedossa Pierre, Belghiti Jacques, Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis, 10.1002/hep.22734